OIS at AAO 2015

Inotek Pharmaceuticals

Nov 12, 2015 11:09am ‐ Nov 12, 2015 11:17am


Inotek is a clinical-stage biopharmaceutical company operating in Lexington MA that focuses on the discovery, development, and commercialization of novel therapeutics for the treatment of serious diseases of the eye. Inotek is developing trabodenoson, an adenosine mimetic targeting the A1 receptor, to reduce IOP through a novel mechanism of action.


You must be logged in and own this session in order to post comments.